XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Beginning Balance (in shares) at Dec. 31, 2019   37,390      
Beginning Balance at Dec. 31, 2019 $ 1,489,142 $ 374 $ 216,162 $ 1,413,453 $ (140,847)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 56,747     56,747  
Other comprehensive income (loss)          
Cumulative translation adjustment (31,102)       (31,102)
Issuance of common stock in connection with:          
Exercise of options (in shares)   34      
Exercise of options 1,207 $ 1 1,206    
Restricted share grants (in shares)   136      
Restricted share grants (6,767) $ 1 (6,768)    
Stock units issued under incentive compensation plan 2,314   2,314    
Purchase and retirement of common stock (in shares)   (450)      
Purchase and retirement of common stock (50,311) $ (5) (50,306)    
Share-based compensation 7,454   7,454    
Ending Balance (in shares) at Mar. 31, 2020   37,110      
Ending Balance at Mar. 31, 2020 1,468,684 $ 371 170,062 1,470,200 (171,949)
Beginning Balance (in shares) at Dec. 31, 2019   37,390      
Beginning Balance at Dec. 31, 2019 1,489,142 $ 374 216,162 1,413,453 (140,847)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 104,921        
Other comprehensive income (loss)          
Cumulative translation adjustment (21,534)        
Issuance of common stock in connection with:          
Stock units issued under incentive compensation plan 2,314        
Ending Balance (in shares) at Jun. 30, 2020   36,710      
Ending Balance at Jun. 30, 2020 1,479,103 $ 367 122,743 1,518,374 (162,381)
Beginning Balance (in shares) at Mar. 31, 2020   37,110      
Beginning Balance at Mar. 31, 2020 1,468,684 $ 371 170,062 1,470,200 (171,949)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 48,174     48,174  
Other comprehensive income (loss)          
Cumulative translation adjustment 9,568       9,568
Issuance of common stock in connection with:          
Exercise of options (in shares)   33      
Exercise of options 1,191   1,191    
Restricted share grants (in shares)   38      
Restricted share grants (2,154) $ 1 (2,155)    
Purchase and retirement of common stock (in shares)   (471)      
Purchase and retirement of common stock (51,053) $ (5) (51,048)    
Share-based compensation 4,693   4,693    
Ending Balance (in shares) at Jun. 30, 2020   36,710      
Ending Balance at Jun. 30, 2020 $ 1,479,103 $ 367 122,743 1,518,374 (162,381)
Beginning Balance (in shares) at Dec. 31, 2020 34,481 34,481      
Beginning Balance at Dec. 31, 2020 $ 1,400,181 $ 345 0 1,506,271 (106,435)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 64,496     64,496  
Other comprehensive income (loss)          
Cumulative translation adjustment (5,242)       (5,242)
Issuance of common stock in connection with:          
Exercise of options (in shares)   12      
Exercise of options 434   434    
Restricted share grants (in shares)   157      
Restricted share grants (7,231) $ 1 (7,232)    
Stock units issued under incentive compensation plan 2,603   2,603    
Purchase and retirement of common stock (in shares)   (422)      
Purchase and retirement of common stock (46,133) $ (4) (3,047) (43,082)  
Share-based compensation 7,242   7,242    
Ending Balance (in shares) at Mar. 31, 2021   34,228      
Ending Balance at Mar. 31, 2021 $ 1,416,350 $ 342 0 1,527,685 (111,677)
Beginning Balance (in shares) at Dec. 31, 2020 34,481 34,481      
Beginning Balance at Dec. 31, 2020 $ 1,400,181 $ 345 0 1,506,271 (106,435)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 127,278        
Other comprehensive income (loss)          
Cumulative translation adjustment 565        
Issuance of common stock in connection with:          
Stock units issued under incentive compensation plan $ 2,603        
Purchase and retirement of common stock     (3,000)    
Ending Balance (in shares) at Jun. 30, 2021 34,282 34,282      
Ending Balance at Jun. 30, 2021 $ 1,489,210 $ 343 4,270 1,590,467 (105,870)
Beginning Balance (in shares) at Mar. 31, 2021   34,228      
Beginning Balance at Mar. 31, 2021 1,416,350 $ 342 0 1,527,685 (111,677)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 62,782     62,782  
Other comprehensive income (loss)          
Cumulative translation adjustment 5,807       5,807
Issuance of common stock in connection with:          
Exercise of options (in shares)   33      
Exercise of options 1,137 $ 1 1,136    
Restricted share grants (in shares)   21      
Restricted share grants (1,814)   (1,814)    
Share-based compensation $ 4,948   4,948    
Ending Balance (in shares) at Jun. 30, 2021 34,282 34,282      
Ending Balance at Jun. 30, 2021 $ 1,489,210 $ 343 $ 4,270 $ 1,590,467 $ (105,870)